|
1
|
Rosebush MS, Rao SK, Samant S, Gu W,
Handorf CR, Pfeffer LM and Nosrat CA: Oral cancer: Enduring
characteristics and emerging trends. J Tenn Dent Assoc. 91:24–29.
2011.PubMed/NCBI
|
|
2
|
Brocklehurst PR, Baker SR and Speight PM:
Oral cancer screening: What have we learnt and what is there still
to achieve? Future Oncol. 6:299–304. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiu MT, Hu JW, Yin R and Xu L: Long
noncoding RNA: An emerging paradigm of cancer research. Tumour
Biol. 34:613–620. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eades G, Zhang YS, Li QL, Xia JX, Yao Y
and Zhou Q: Long non-coding RNAs in stem cells and cancer. World J
Clin Oncol. 5:134–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wylie AA, Murphy SK, Orton TC and Jirtle
RL: Novel imprinted DLK1/GTL2 domain on human chromosome 14
contains motifs that mimic those implicated in IGF2/H19 regulation.
Genome Res. 10:1711–1718. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Balik V, Srovnal J, Sulla I, Kalita O,
Foltanova T, Vaverka M, Hrabalek L and Hajduch M: MEG3: A novel
long noncoding potentially tumour-suppressing RNA in meningiomas. J
Neurooncol. 112:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y, Zhong Y, Wang Y, Zhang X, Batista
DL, Gejman R, Ansell PJ, Zhao J, Weng C and Klibanski A: Activation
of p53 by MEG3 non-coding RNA. J Biol Chem. 282:24731–24742. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schmidt JV, Matteson PG, Jones BK, Guan XJ
and Tilghman SM: The Dlk1 and Gtl2 genes are linked
and reciprocally imprinted. Genes Dev. 14:1997–2002.
2000.PubMed/NCBI
|
|
14
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
15
|
Modali SD, Parekh VI, Kebebew E and
Agarwal SK: Epigenetic regulation of the lncRNA MEG3 and its target
c-MET in pancreatic neuroendocrine tumors. Mol Endocrinol.
29:224–237. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Braconi C, Kogure T, Valeri N, Huang N,
Nuovo G, Costinean S, Negrini M, Miotto E, Croce CM and Patel T:
microRNA-29 can regulate expression of the long non-coding RNA gene
MEG3 in hepatocellular cancer. Oncogene. 30:4750–4756. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao W, Chen X and He M: Inhibition of the
Jagged/Notch pathway inhibits retinoblastoma cell proliferation via
suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β catenin signaling
pathways. Mol Med Rep. 10:453–458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia Y, He Z, Liu B, Wang P and Chen Y:
Downregulation of Meg3 enhances cisplatin resistance of lung cancer
cells through activation of the WNT/β-catenin signaling pathway.
Mol Med Rep. 12:4530–4537. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rowe MK and Chuang DM: Lithium
neuroprotection: Molecular mechanisms and clinical implications.
Expert Rev Mol Med. 6:1–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Binnerts ME, Kim KA, Bright JM, Patel SM,
Tran K, Zhou M, Leung JM, Liu Y, Lomas WE III, Dixon M, et al:
R-Spondin1 regulates Wnt signaling by inhibiting internalization of
LRP6. Proc Natl Acad Sci USA. 104:14700–14705. 2007. View Article : Google Scholar : PubMed/NCBI
|
